(VIANEWS) – TG Therapeutics (TGTX), InterDigital (IDCC), Northern Technologies International Corporation (NTIC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. TG Therapeutics (TGTX)
67.5% sales growth and 43.93% return on equity
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.
Earnings Per Share
As for profitability, TG Therapeutics has a trailing twelve months EPS of $0.3.
PE Ratio
TG Therapeutics has a trailing twelve months price to earnings ratio of 60. Meaning, the purchaser of the share is investing $60 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.93%.
Sales Growth
TG Therapeutics’s sales growth is 277.6% for the current quarter and 67.5% for the next.
Yearly Top and Bottom Value
TG Therapeutics’s stock is valued at $18.00 at 06:22 EST, way under its 52-week high of $26.95 and way higher than its 52-week low of $6.46.
2. InterDigital (IDCC)
24.3% sales growth and 30.28% return on equity
InterDigital, Inc. operates as a global research and development company with focus primarily on wireless, visual, and related technologies. It designs and develops technologies that enable connected in a range of communications and entertainment products and services. It licenses or intend to license its innovations to companies providing products and services, including wireless communications, consumer electronics, personal computer, and automotive, as well as cloud-based services, such as video streaming. It designs and develops a range of innovations for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, 5G, and IEEE 802-related products and networks. The company also develops cellular technologies, such as technologies related to CDMA, TDMA, OFDM/OFDMA, and MIMO for use in 2G, 3G, 4G, and 5G wireless networks, as well as mobile terminal devices; and 3GPP technology portfolio in 5G, 5G, advanced and 6G, as well as technologies for automobiles, wearables, smart homes, drones, and other connected consumer electronic products. In addition, it provides video coding and transmission technologies; and engages in the research and development of artificial intelligence. Further, the company's patented technologies are used in various products that include smartphones, tablets, consumer electronics, and base stations; televisions, laptops, gaming consoles, set-top boxes, streaming devices, and connected automobiles. InterDigital, Inc. was incorporated in 1972 and is headquartered in Wilmington, Delaware.
Earnings Per Share
As for profitability, InterDigital has a trailing twelve months EPS of $6.92.
PE Ratio
InterDigital has a trailing twelve months price to earnings ratio of 16.99. Meaning, the purchaser of the share is investing $16.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.28%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 58.2% and a negative 54.7%, respectively.
Moving Average
InterDigital’s value is above its 50-day moving average of $107.63 and way higher than its 200-day moving average of $99.46.
3. Northern Technologies International Corporation (NTIC)
18.8% sales growth and 8.61% return on equity
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Earnings Per Share
As for profitability, Northern Technologies International Corporation has a trailing twelve months EPS of $0.48.
PE Ratio
Northern Technologies International Corporation has a trailing twelve months price to earnings ratio of 34.23. Meaning, the purchaser of the share is investing $34.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.61%.
Volume
Today’s last reported volume for Northern Technologies International Corporation is 43188 which is 2.84% below its average volume of 44453.
Yearly Top and Bottom Value
Northern Technologies International Corporation’s stock is valued at $16.43 at 06:22 EST, way below its 52-week high of $19.63 and way above its 52-week low of $10.08.
4. Reinsurance Group of America (RGA)
17.6% sales growth and 10.05% return on equity
Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions. It also provides reinsurance for mortality, morbidity, lapse, and investment-related risk associated with products; and reinsurance for investment-related risks. In addition, the company develops and markets technology solutions; and provides consulting and outsourcing solutions for the insurance and reinsurance industries. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1973 and is headquartered in Chesterfield, Missouri.
Earnings Per Share
As for profitability, Reinsurance Group of America has a trailing twelve months EPS of $12.89.
PE Ratio
Reinsurance Group of America has a trailing twelve months price to earnings ratio of 15.82. Meaning, the purchaser of the share is investing $15.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.05%.
Moving Average
Reinsurance Group of America’s worth is above its 50-day moving average of $199.10 and way above its 200-day moving average of $171.67.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.4 and the estimated forward annual dividend yield is 1.68%.
Previous days news about Reinsurance Group of America(RGA)
- According to Zacks on Tuesday, 2 July, "Some better-ranked stocks from the insurance industry are Reinsurance Group of America (RGA Quick QuoteRGA – Free Report) , Palomar Holdings (PLMR Quick QuotePLMR – Free Report) and ProAssurance (PRA Quick QuotePRA – Free Report) ."
5. WEX (WEX)
9% sales growth and 15.34% return on equity
WEX Inc. operates a commerce platform in the United States and internationally. The Fleet Solutions segment offers fleet vehicle payment solutions, transaction processing, and information management services. It also provides account and account retention services; authorization and billing inquiries, and account maintenance services; account management; credit and collections services; merchant services; analytics solutions; and ancillary services and tools to fleets to manage expenses and capital requirements. This segment markets its products directly and indirectly to businesses and government agencies with fleets of commercial vehicles; and indirectly through co-branded and private label relationships. The Travel and Corporate Solutions segment provides payment solutions, including embedded payments; and accounts payable automation and spend management solutions. Its products include virtual cards that are used for transactions where no physical card is presented. This segment markets its products directly and indirectly to customers in travel, fintech, insurance, consumer bill pay, and media verticals, as well as businesses and financial institutions. The Health and Employee Benefit Solutions segment offers software-as-a-service (SaaS) platform for consumer directed healthcare benefits and full-service benefit enrollment solutions. Its SaaS platform includes embedded payment solutions and plan administration services for consumer-directed health benefits; COBRA accounts; and benefit enrollment and administration services. This segment also provides custodial and depository services for health savings accounts; and payroll-related benefits. This segment markets its products through third-party administrators, financial institutions, payroll providers, and health plans. The company was formerly known as Wright Express Corporation and changed its name to WEX Inc. in October 2012. WEX Inc. was founded in 1983 and is based in Portland, Maine.
Earnings Per Share
As for profitability, WEX has a trailing twelve months EPS of $6.14.
PE Ratio
WEX has a trailing twelve months price to earnings ratio of 27.59. Meaning, the purchaser of the share is investing $27.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.7%, now sitting on 2.59B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 4.7% and 11.4%, respectively.
Volume
Today’s last reported volume for WEX is 338717 which is 13.93% above its average volume of 297282.
